Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial-Reference-Cited by-同舟云学术

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Published:2006-04 Issue:9518 Volume:367 Page:1247-1255
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Harper Diane M,Franco Eduardo L,Wheeler Cosette M,Moscicki Anna-Barbara,Romanowski Barbara,Roteli-Martins Cecilia M,Jenkins David,Schuind Anne,Costa Clemens Sue Ann,Dubin Gary

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Worldwide burden of gynaecological cancer: the size of the problem;Sankaranarayanan;Best Pract Res Clin Obstet Gynaecol,2006

3. The causal relation between human papillomavirus and cervical cancer;Bosch;J Clin Pathol,2002

4. Carcinogenicity of human papillomaviruses;Cogliano;Lancet Oncol,2005

5. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide;Walboomers;J Pathol,1999

Cited by 1269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine Effectiveness Of Bivalent HPV Vaccination Against Genital HPV Of A Catch-Up Campaign And 12 Years Routine Vaccination For Girls-Only: A Biennial Repeated Cross-Sectional Study;2024-07-19

2. Neighborhood-level social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival;JNCI Cancer Spectrum;2024-07-01

3. Determinants of Parental Intention to Vaccinate Young Adolescent Girls against the Human Papillomavirus in Taiwan: An Online Survey Study;Vaccines;2024-05-11

4. HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity;Human Vaccines & Immunotherapeutics;2024-04-03

5. Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women;Pathogens;2024-02-27